Reports

Ideas That Generate Results

List of Figures:

Figure 5-1: Molecular Diagnostics Market (Billion US$), 2011-2015
Figure 5-2: Molecular Diagnostics Market by Segment (%), 2011
Figure 5-3: Molecular Diagnostics Market by Player (%), 2011
Figure 5-4: Share of Infectious Diseases in Molecular Diagnostics Market (2011 & 2015)
Figure 5-5: Infectious Diseases Molecular Diagnostics Market (Billion US$), 2011-2015
Figure 6-1: Infectious Diseases Molecular Diagnostics Market by Disease Segment (%), 2011 & 2015
Figure 6-2: New Cases of HIV/AIDS (Million), 2009 & 2010
Figure 6-3: Prevalence of HIV/AIDS (Million), 2011 & 2015
Figure 6-4: HIV/AIDS Molecular Diagnostics Market (Million US$), 2011-2015
Figure 6-5: Prevalence of Hepatitis B (Billion), 2011 & 2015
Figure 6-6: HBV Molecular Diagnostics Market (Million US$), 2011-2015
Figure 6-7: HCV Molecular Diagnostics Market (Million US$), 2011-2015
Figure 6-8: Number of New Cervical Cancer Cases (Million), 2011 & 2015
Figure 6-9: HPV Molecular Diagnostics Market (Million US$), 2011-2015
Figure 6-10: CT/GC Molecular Diagnostics Market (Million US$), 2011-2015
Figure 7-1: US - Approved Molecular Diagnostic Products by Segment (%)

List of Tables:

Table 3-1: Key PCR based Tests for Infectious Diseases
Table 3-2: Key Real Time PCR based Tests for Infectious Diseases
Table 3-3: Key Multiplex PCR based Tests for Infectious Diseases
Table 3-4: Key TMA based Tests for Infectious Diseases
Table 3-5: Key NASBA based Tests for Infectious Diseases
Table 3-6: Key SDA based Tests for Infectious Diseases
Table 3-7: Key Probe based Tests for Infectious Diseases
Table 3-8: Key Microarray based Tests for Infectious Diseases
Table 3-9: Key Sequencing based Tests for Infectious Diseases
Table 6-1: Prevalence of HIV/AIDS by Region (2010)
Table 6-2: FDA Approved HIV Molecular Diagnostics Tests
Table 6-3: Prevalence of Chronic Hepatitis B by Region
Table 6-4: FDA Approved Hepatitis Molecular Diagnostics Tests
Table 6-5: Contribution of HPV in Cancer by Type
Table 6-6: HPV Prevalence by Type
Table 6-7: HPV Prevalence by Region
Table 6-8: FDA Approved HPV Molecular Diagnostics Tests
Table 6-9: Estimated New Cases of Chlamydia in Adults (Million)
Table 6-10: Estimated New Cases of Gonorrhea in Adults (Million)
Table 6-11: FDA Approved CT/GC Molecular Diagnostics Tests
Table 8-1: Abbott Molecular - Infectious Disease Molecular Diagnostic Products
Table 8-2: BD Diagnostics - Infectious Disease Molecular Diagnostic Products
Table 8-3: Siemens Healthcare - Infectious Disease Diagnostic Products
Table 8-4: bioMerieux - Infectious Disease Molecular Diagnostic Products
Table 8-5: Gen-Probe - Key Infectious Disease Diagnostic Products
Table 8-6: Cepheid - Infectious Disease Diagnostic Products
Table 8-7: Qiagen N.V. - Infectious Disease Diagnostic Products
Table 8-8: Roche Molecular Diagnostics - Infectious Disease Diagnostics Products